Beauty Health Clocks 13% Growth In Q2 Revenues On Strong Demand For Hydrafacial
The Beauty Health Company (NASDAQ: SKIN) registered
Valvoline’s Q3: Earnings Beat, Margin Improvement, CEO Change & More
Valvoline Inc. (NYSE: VVV) reported third-quarter FY23 sales growth of 19% year-on-year to $376.20 million,
Star Bulk Carriers President, Hamish Norton, Gives An Update On Company Strategy And The Dry Bulk Sector Outlook
With the occasion of the recently announced financial and operational results of Q2 2023, Mr. Hamish Norton, President of Star Bulk Carriers (NASDAQ:SBLK) participated in Capital Link's Trending News Podcast Series,
IPA Responds To 13D Filing By Ingalls & Snyder, LLC; IPA Announced That It Has Recently Begun Interviewing Potential Candidates To Refresh Its Board Of Directors In Its Search For The Optimal Board Composition
IPA responds to 13D Filing by Ingalls & Snyder, LLCIPA (IMMUNOPRECISE ANTIBODIES LTD.) (the "Company" or "IPA") (NASDAQ:IPA), an advanced biotherapeutic research and technology company, today issued the following
Spruce Point Capital Management Announces Investment Opinion: Releases Report And Strong Sell Research Opinion On Xylem Inc.
NOTE TO EDITORS: The Following is an Investment Opinion Issued by Spruce Point Capital Management
Provides Evidence That Xylem's Recent $7.5 Billion Acquisition of Evoqua Water Technologies Combines Two Troubled Companies That Will Fail to Deliver Value for Shareholders
Quanterix Appoints Vandana Sriram As Chief Financial Officer, Effective August 21, 2023
Quanterix Corporation (NASDAQ:QTRX), a company fueling scientific discovery and breakthrough diagnostics through ultrasensitive biomarker detection, today announced that it has appointed Vandana Sriram, CPA, as Chief
Why LivePerson Shares Are Surging Today
LivePerson Inc (NASDAQ: LPSN) shares are trading higher by around 13% after the company reported a
Salarius Pharmaceuticals Announces Plans To Explore Strategic Alternatives And Implement Measures To Extend Its Resources
Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX), a clinical-stage biopharmaceutical company using protein inhibition and protein degradation to develop cancer therapies for patients in need of new treatment
Microvast Appoints Zach Ward As President To Drive Ongoing U.S. Expansion
Microvast Holdings, Inc. (NASDAQ:MVST) ("Microvast" or the "Company"), a technology innovator that designs, develops, and manufactures lithium-ion battery solutions, is excited to announce the
Mirati Therapeutics Announces Departure Of Chief Executive Officer David Meek; Charles M. Baum, M.D., Ph.D. Assumes Role Of Interim CEO
Charles M. Baum, M.D., Ph.D. assumes role of interim CEO
SAN DIEGO, Aug. 8, 2023 /PRNewswire/ -- Mirati Therapeutics, Inc.® (NASDAQ:MRTX), a commercial stage biotechnology company today announced